{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:16:09Z","timestamp":1790694969021,"version":"4.1.0"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2019JDPT0015"],"award-info":[{"award-number":["2019JDPT0015"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["ZYJC18003"],"award-info":[{"award-number":["ZYJC18003"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.neuropharm.2022.108966","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T02:38:07Z","timestamp":1642819087000},"page":"108966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Exploring the dual character of metformin in Alzheimer's disease"],"prefix":"10.1016","volume":"207","author":[{"given":"Pingping","family":"Ning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8281-4459","authenticated-orcid":false,"given":"Tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2022.108966_bib1","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1038\/s41598-021-85579-7","article-title":"'A single arm trial using passive simulated jogging for blunting acute hyperglycemia'","volume":"11","author":"Adams","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2022.108966_bib2","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1093\/cercor\/bhy078","article-title":"'Relationships between tau and glucose metabolism reflect Alzheimer's disease pathology in cognitively normal older adults'","volume":"29","author":"Adams","year":"2019","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2022.108966_bib3","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1212\/WNL.58.7.1050","article-title":"'Randomized pilot study of nimesulide treatment in Alzheimer's disease'","volume":"58","author":"Aisen","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2022.108966_bib4","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.pharep.2019.04.015","article-title":"'The protective effect of metformin in scopolamine-induced learning and memory impairment in rats'","volume":"71","author":"Aksoz","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2022.108966_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.aat0473","article-title":"'Glia as architects of central nervous system formation and function'","volume":"362","author":"Allen","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.108966_bib6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.brainresbull.2016.02.005","article-title":"'Neuroprotective effects of metformin against Abeta-mediated inhibition of long-term potentiation in rats fed a high-fat diet'","volume":"121","author":"Asadbegi","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2022.108966_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13024-016-0082-7","article-title":"'Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy'","volume":"11","author":"Barini","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2022.108966_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neubiorev.2017.04.030","article-title":"'The effects of aging in the hippocampus and cognitive decline'","volume":"79","author":"Bettio","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2022.108966_bib9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/ncb2788","article-title":"'Emerging regulation and functions of autophagy'","volume":"15","author":"Boya","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neuropharm.2022.108966_bib10","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2174\/156720512802455386","article-title":"'Roles of glycogen synthase kinase 3 in Alzheimer's disease'","volume":"9","author":"Cai","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuropharm.2022.108966_bib11","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3233\/JAD-180263","article-title":"'Metformin use associated with reduced risk of dementia in patients with diabetes: a systematic review and meta-analysis'","volume":"65","author":"Campbell","year":"2018","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuropharm.2022.108966_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/nu12020382","article-title":"'Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: data from an in vivo model'","volume":"12","author":"Cassano","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.neuropharm.2022.108966_bib13","first-page":"1421430","article-title":"'Metformin alleviated abeta-induced apoptosis via the suppression of JNK MAPK signaling pathway in cultured hippocampal neurons'","author":"Chen","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.neuropharm.2022.108966_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuropharm.2015.07.023","article-title":"'Antidiabetic drugs restore abnormal transport of amyloid-beta across the blood-brain barrier and memory impairment in db\/db mice'","volume":"101","author":"Chen","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.108966_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2018.09.008","article-title":"'Metformin attenuates diabetes-induced tau hyperphosphorylation in vitro and in vivo by enhancing autophagic clearance'","volume":"311","author":"Chen","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.108966_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10100706","article-title":"'Metformin enhances excitatory synaptic transmission onto hippocampal CA1 pyramidal neurons'","volume":"10","author":"Chen","year":"2020","journal-title":"Brain Sci"},{"key":"10.1016\/j.neuropharm.2022.108966_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13195-020-00761-9","article-title":"'Metformin attenuates plaque-associated tau pathology and reduces amyloid-beta burden in APP\/PS1 mice'","volume":"13","author":"Chen","year":"2021","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neuropharm.2022.108966_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12264-013-1423-y","article-title":"'Oxidative stress in Alzheimer's disease'","volume":"30","author":"Chen","year":"2014","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neuropharm.2022.108966_bib19","doi-asserted-by":"crossref","first-page":"e12801","DOI":"10.1111\/acel.12801","article-title":"'The emerging roles of protein homeostasis-governing pathways in Alzheimer's disease'","volume":"17","author":"Cheng","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.neuropharm.2022.108966_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.yexcr.2016.08.013","article-title":"'Metformin activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against Amyloid-beta-induced mitochondrial dysfunction'","volume":"347","author":"Chiang","year":"2016","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.neuropharm.2022.108966_bib21","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1038\/emm.2013.147","article-title":"'Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease'","volume":"46","author":"Choi","year":"2014","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neuropharm.2022.108966_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/bpa.12655","article-title":"'Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline'","volume":"29","author":"Chornenkyy","year":"2019","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2022.108966_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3233\/JAD-190639","article-title":"'Effect of advanced glycation end products on the progression of Alzheimer's disease'","volume":"72","author":"Chou","year":"2019","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuropharm.2022.108966_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.yexcr.2017.01.017","article-title":"'Metformin activation of AMPK suppresses AGE-induced inflammatory response in hNSCs'","volume":"352","author":"Chung","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.neuropharm.2022.108966_bib25","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2337\/dci20-0022","article-title":"'Precision medicine in diabetes: a consensus report from the American diabetes association (ADA) and the European association for the study of diabetes (EASD)'","volume":"43","author":"Chung","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neuropharm.2022.108966_bib26","doi-asserted-by":"crossref","first-page":"10186","DOI":"10.1073\/pnas.1609896113","article-title":"'Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes'","volume":"113","author":"Chung","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.108966_bib27","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/archneurol.2012.2194","article-title":"'Safety and tolerability of the gamma-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease'","volume":"69","author":"Coric","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2022.108966_bib28","doi-asserted-by":"crossref","first-page":"620641","DOI":"10.3389\/fonc.2020.620641","article-title":"'Metformin: targeting the metabolo-epigenetic link in cancer biology'","volume":"10","author":"Cuyas","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuropharm.2022.108966_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102581","article-title":"'Inflammatory cascade in Alzheimer's disease pathogenesis: a review of experimental findings'","volume":"10","author":"de Oliveira","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2022.108966_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41392-021-00493-8","article-title":"'Metformin targets Clusterin to control lipogenesis and inhibit the growth of bladder cancer cells through SREBP-1c\/FASN axis'","volume":"6","author":"Deng","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.neuropharm.2022.108966_bib31","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1152\/physrev.00062.2017","article-title":"'Brain glucose metabolism: integration of energetics with function'","volume":"99","author":"Dienel","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2022.108966_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3233\/JAD-141332","article-title":"'Metformin treatment alters memory function in a mouse model of Alzheimer's disease'","volume":"44","author":"DiTacchio","year":"2015","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuropharm.2022.108966_bib33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.fertnstert.2016.09.023","volume":"107","author":"Elkind-Hirsch","year":"2017","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.neuropharm.2022.108966_bib34","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3233\/JAD-181240","article-title":"'Metformin improves learning and memory in the SAMP8 mouse model of Alzheimer's disease'","volume":"68","author":"Farr","year":"2019","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuropharm.2022.108966_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12933-015-0304-2","article-title":"'Effect of metformin monotherapy on cardiovascular diseases and mortality: a retrospective cohort study on Chinese type 2 diabetes mellitus patients'","volume":"14","author":"Fung","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.neuropharm.2022.108966_bib36","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nm.4335","article-title":"'Metformin ameliorates core deficits in a mouse model of fragile X syndrome'","volume":"23","author":"Gantois","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2022.108966_bib37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12974-019-1450-3","article-title":"'Urolithin A attenuates memory impairment and neuroinflammation in APP\/PS1 mice'","volume":"16","author":"Gong","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2022.108966_bib38","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1172\/JCI138179","article-title":"'Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration'","volume":"130","author":"Gratuze","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2022.108966_bib39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jalz.2008.09.004","article-title":"'Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results'","volume":"5","author":"Group","year":"2009","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuropharm.2022.108966_bib40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/archdischild-2015-308336","article-title":"'What is a normal blood glucose?'","volume":"101","author":"Guemes","year":"2016","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.neuropharm.2022.108966_bib41","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.2337\/db14-0020","article-title":"'Diabetes and cardiovascular disease in older adults: current status and future directions'","volume":"63","author":"Halter","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2022.108966_bib42","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1007\/s12035-021-02400-2","article-title":"'Inhibition of 2-arachidonoylglycerol metabolism alleviates neuropathology and improves cognitive function in a tau mouse model of Alzheimer's disease'","volume":"58","author":"Hashem","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.108966_bib43","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","article-title":"'Hallmarks of cellular senescence'","volume":"28","author":"Hernandez-Segura","year":"2018","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.neuropharm.2022.108966_bib44","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","article-title":"'Complement and microglia mediate early synapse loss in Alzheimer mouse models'","volume":"352","author":"Hong","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.108966_bib45","doi-asserted-by":"crossref","first-page":"e87095","DOI":"10.1371\/journal.pone.0087095","article-title":"'Diabetes mellitus and the risk of Alzheimer's disease: a nationwide population-based study'","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2022.108966_bib46","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","article-title":"'Age-Dependent effects of apoE reduction using antisense oligonucleotides in a model of beta-amyloidosis'","volume":"96","author":"Huynh","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.108966_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fmolb.2014.00009","article-title":"'Differential effects of glycation on protein aggregation and amyloid formation'","volume":"1","author":"Iannuzzi","year":"2014","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.neuropharm.2022.108966_bib48","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3233\/JAD-200049","article-title":"'Drug repositioning for Alzheimer's disease: finding hidden clues in old drugs'","volume":"74","author":"Ihara","year":"2020","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuropharm.2022.108966_bib49","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1532-5415.2012.03916.x","article-title":"'Metformin, other antidiabetic drugs, and risk of Alzheimer's disease: a population-based case-control study'","volume":"60","author":"Imfeld","year":"2012","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.neuropharm.2022.108966_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2016.12.010","article-title":"The effects of sitagliptin, a DPP-4 inhibitor, on cognitive functions in elderly diabetic patients with or without Alzheimer\u2019s disease","author":"Isik","year":"2017","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1016\/j.neuropharm.2022.108966_bib50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/brain\/awx194","article-title":"'The cerebellum in Alzheimer's disease: evaluating its role in cognitive decline'","volume":"141","author":"Jacobs","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2022.108966_bib137","author":"Kazkayasi","year":"2016","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.neuropharm.2022.108966_bib51","doi-asserted-by":"crossref","first-page":"21830","DOI":"10.1073\/pnas.0912793107","article-title":"'Biguanide metformin acts on tau phosphorylation via mTOR\/protein phosphatase 2A (PP2A) signaling'","volume":"107","author":"Kickstein","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.108966_bib52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/WAD.0000000000000202","article-title":"'Effects of the insulin sensitizer metformin in alzheimer disease: pilot data from a randomized placebo-controlled crossover study'","volume":"31","author":"Koenig","year":"2017","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neuropharm.2022.108966_bib139","doi-asserted-by":"crossref","DOI":"10.1111\/ggi.13692","article-title":"Taking metformin and cognitive function change in older patients with diabetes","author":"Koo","year":"2019","journal-title":"Geriatrics Gerontology International"},{"key":"10.1016\/j.neuropharm.2022.108966_bib53","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3233\/JAD-2009-1011","article-title":"'Risk of incident Alzheimer's disease in diabetic patients: a systematic review of prospective trials'","volume":"16","author":"Kopf","year":"2009","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuropharm.2022.108966_bib54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pnpbp.2017.06.002","article-title":"'Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus'","volume":"79","author":"Kuan","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.108966_bib55","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1001\/jama.2019.20939","article-title":"'In alzheimer research, glucose metabolism moves to center stage'","volume":"323","author":"Kuehn","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2022.108966_bib56","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3233\/JAD-181017","article-title":"'Metformin therapy aggravates neurodegenerative processes in ApoE-\/- mice'","volume":"68","author":"Kuhla","year":"2019","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuropharm.2022.108966_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120420","article-title":"'Anti-abeta oligomer IgG and surface sialic acid in intravenous immunoglobulin: measurement and correlation with clinical outcomes in Alzheimer's disease treatment'","volume":"10","author":"Kwon","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2022.108966_bib58","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2337\/dc19-0906","article-title":"'Severe hypoglycemia and cognitive function in older adults with type 1 diabetes: the study of longevity in diabetes (SOLID)',","volume":"43","author":"Lacy","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neuropharm.2022.108966_bib59","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0006-8993(02)03476-5","article-title":"'Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation'","volume":"956","author":"Lalonde","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.108966_bib60","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1177\/0271678X17733640","article-title":"'Recurrent moderate hypoglycemia exacerbates oxidative damage and neuronal death leading to cognitive dysfunction after the hypoglycemic coma'","volume":"39","author":"Languren","year":"2019","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2022.108966_bib61","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuropharm.2014.06.026","article-title":"'Comparison of the independent and combined effects of sub-chronic therapy with metformin and a stable GLP-1 receptor agonist on cognitive function, hippocampal synaptic plasticity and metabolic control in high-fat fed mice'","volume":"86","author":"Lennox","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.108966_bib62","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/gps.2723","article-title":"'Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial'","volume":"27","author":"Leoutsakos","year":"2012","journal-title":"Int. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.108966_bib63","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3233\/JAD-2008-15112","article-title":"'Differential changes in synaptic proteins in the Alzheimer frontal cortex with marked increase in PSD-95 postsynaptic protein'","volume":"15","author":"Leuba","year":"2008","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuropharm.2022.108966_bib64","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.pbb.2012.03.002","article-title":"'Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice'","volume":"101","author":"Li","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2022.108966_bib65","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/cns.12678","article-title":"'Dendrobium nobile Lindl alkaloid, a novel autophagy inducer, protects against axonal degeneration induced by Abeta25-35 in hippocampus neurons in vitro'","volume":"23","author":"Li","year":"2017","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2022.108966_bib140","article-title":"Evaluation of Metformin on Cognitive Improvement in Patients With Non-dementia Vascular Cognitive Impairment and Abnormal Glucose Metabolism","author":"Lin","year":"2018","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.108966_bib66","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"'Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases'","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.108966_bib67","doi-asserted-by":"crossref","first-page":"146871","DOI":"10.1016\/j.brainres.2020.146871","article-title":"'Dendrobium nobile Lindl alkaloid and metformin ameliorate cognitive dysfunction in senescence-accelerated mice via suppression of endoplasmic reticulum stress'","volume":"1741","author":"Liu","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.108966_bib68","first-page":"2315106","article-title":"'Metformin ameliorates abeta pathology by insulin-degrading enzyme in a transgenic mouse model of Alzheimer's disease'","author":"Lu","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2022.108966_bib69","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JAD-150493","article-title":"'Metformin in amnestic mild cognitive impairment: results of a pilot randomized placebo controlled clinical trial'","volume":"51","author":"Luchsinger","year":"2016","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuropharm.2022.108966_bib70","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1152\/physrev.00014.2003","article-title":"'Long-term potentiation and memory'","volume":"84","author":"Lynch","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2022.108966_bib71","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1007\/s11095-017-2199-y","article-title":"'Metformin - a future therapy for neurodegenerative diseases : theme: drug discovery, development and delivery in Alzheimer's disease guest editor: davide Brambilla'","volume":"34","author":"Markowicz-Piasecka","year":"2017","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.neuropharm.2022.108966_bib72","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/ncomms3192","article-title":"'Metformin improves healthspan and lifespan in mice'","volume":"4","author":"Martin-Montalvo","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2022.108966_bib73","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41420-017-0003-8","article-title":"'Inhibition of the MID1 protein complex: a novel approach targeting APP protein synthesis'","volume":"4","author":"Matthes","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2022.108966_bib74","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1007\/s00125-012-2686-y","article-title":"\u2018A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin\u2019","volume":"55","author":"McNeilly","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.neuropharm.2022.108966_bib75","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.arcmed.2012.11.009","article-title":"'Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD'","volume":"43","author":"Mendez","year":"2012","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.neuropharm.2022.108966_bib76","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fnagi.2014.00165","article-title":"'beta-secretase inhibitor; a promising novel therapeutic drug in Alzheimer's disease'","volume":"6","author":"Menting","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2022.108966_bib77","doi-asserted-by":"crossref","first-page":"106893","DOI":"10.1016\/j.yebeh.2019.106893","article-title":"'Metformin and trimetazidine ameliorate diabetes-induced cognitive impediment in status epileptic rats'","volume":"104","author":"Mohamed","year":"2020","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2022.108966_bib78","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/mp.2016.51","article-title":"'Insulin signaling misregulation underlies circadian and cognitive deficits in a Drosophila fragile X model'","volume":"22","author":"Monyak","year":"2017","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.108966_bib79","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.2337\/dc13-0229","article-title":"'Increased risk of cognitive impairment in patients with diabetes is associated with metformin'","volume":"36","author":"Moore","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neuropharm.2022.108966_bib80","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1017\/S1041610211002511","article-title":"'Cognitive impairment and vitamin B12: a review'","volume":"24","author":"Moore","year":"2012","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.neuropharm.2022.108966_bib81","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1098\/rstb.2002.1230","article-title":"'Long-term potentiation and memory'","volume":"358","author":"Morris","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2022.108966_bib82","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.clinthera.2008.03.007","article-title":"'Achieving glycosylated hemoglobin targets using the combination of repaglinide and metformin in type 2 diabetes: a reanalysis of earlier data in terms of current targets'","volume":"30","author":"Moses","year":"2008","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.108966_bib83","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00213-016-4301-2","article-title":"'Differential metformin dose-dependent effects on cognition in rats: role of Akt'","volume":"233","author":"Mostafa","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2022.108966_bib84","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2174\/1871527317666180809092359","article-title":"'Diabetes mellitus to neurodegenerative disorders: is oxidative stress fueling the flame?'","volume":"17","author":"Mule","year":"2018","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.neuropharm.2022.108966_bib85","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.lfs.2012.10.025","article-title":"'Therapeutic potential of monoacylglycerol lipase inhibitors'","volume":"92","author":"Mulvihill","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2022.108966_bib86","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF00693778","article-title":"'Focal ischemia of the rat brain, with special reference to the influence of plasma glucose concentration'","volume":"73","author":"Nedergaard","year":"1987","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2022.108966_bib87","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.cub.2016.07.017","article-title":"'Increased glucose transport into neurons rescues abeta toxicity in Drosophila'","volume":"26","author":"Niccoli","year":"2016","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2022.108966_bib88","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3389\/fphar.2018.01479","article-title":"'Dendrobium nobile Lindl. Alkaloids decreases the level of intracellular beta-amyloid by improving impaired autolysosomal proteolysis in APP\/PS1 mice'","volume":"9","author":"Nie","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.108966_bib89","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbi.2017.12.009","article-title":"'Metformin treatment prevents amyloid plaque deposition and memory impairment in APP\/PS1 mice'","volume":"69","author":"Ou","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2022.108966_bib90","doi-asserted-by":"crossref","first-page":"686506","DOI":"10.3389\/fnagi.2021.686506","article-title":"'Amelioration of hippocampal insulin resistance reduces tau hyperphosphorylation and cognitive decline induced by isoflurane in mice'","volume":"13","author":"Peng","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2022.108966_bib91","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archneurol.2009.266","article-title":"'Mild cognitive impairment: ten years later'","volume":"66","author":"Petersen","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2022.108966_bib92","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.bbamcr.2015.01.017","article-title":"'Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-kappaB activation: use of insulin to attenuate metformin's effect'","volume":"1853","author":"Picone","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2022.108966_bib93","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.18632\/aging.101004","article-title":"'Biological and biophysics aspects of metformin-induced effects: cortex mitochondrial dysfunction and promotion of toxic amyloid pre-fibrillar aggregates'","volume":"8","author":"Picone","year":"2016","journal-title":"Aging"},{"key":"10.1016\/j.neuropharm.2022.108966_bib94","doi-asserted-by":"crossref","first-page":"173290","DOI":"10.1016\/j.ejphar.2020.173290","article-title":"'Neuroprotective potential of antihyperglycemic drug metformin in streptozocin-induced rat model of sporadic Alzheimer's disease'","volume":"881","author":"Pilipenko","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.108966_bib95","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001370","article-title":"'Association between metformin and neurodegenerative diseases of observational studies: systematic review and meta-analysis'","volume":"8","author":"Ping","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.neuropharm.2022.108966_bib96","doi-asserted-by":"crossref","first-page":"e5088","DOI":"10.1371\/journal.pone.0005088","article-title":"'Gender- and age-dependent gamma-secretase activity in mouse brain and its implication in sporadic Alzheimer disease'","volume":"4","author":"Placanica","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2022.108966_bib97","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4103\/1673-5374.266045","article-title":"'Dietary habits, lifestyle factors and neurodegenerative diseases'","volume":"15","author":"Popa-Wagner","year":"2020","journal-title":"Neural Regan. Res."},{"key":"10.1016\/j.neuropharm.2022.108966_bib98","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/17460441.2015.1041913","article-title":"'Rodent models for Alzheimer's disease drug discovery'","volume":"10","author":"Puzzo","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.neuropharm.2022.108966_bib99","doi-asserted-by":"crossref","first-page":"101317","DOI":"10.1016\/j.arr.2021.101317","article-title":"'Inflammatory pathways in Alzheimer's disease mediated by gut microbiota'","volume":"68","author":"Qian","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuropharm.2022.108966_bib100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"'Alzheimer's disease'","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2022.108966_bib101","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2013.11.048","article-title":"'AMPK activation regulates neuronal structure in developing hippocampal neurons'","volume":"259","author":"Ramamurthy","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.108966_bib102","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.62.1.66","article-title":"'Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study'","volume":"62","author":"Reines","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2022.108966_bib103","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-180740","article-title":"'The role of apolipoprotein E isoforms in Alzheimer's disease'","volume":"68","author":"Roda","year":"2019","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuropharm.2022.108966_bib104","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1007\/s12035-017-0752-7","article-title":"'Metformin inhibits the development of L-DOPA-induced dyskinesia in a murine model of Parkinson's disease'","volume":"55","author":"Ryu","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.108966_bib105","doi-asserted-by":"crossref","first-page":"117861","DOI":"10.1016\/j.lfs.2020.117861","article-title":"'Metformin loaded phosphatidylserine nanoliposomes improve memory deficit and reduce neuroinflammation in streptozotocin-induced Alzheimer's disease model'","volume":"255","author":"Saffari","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2022.108966_bib106","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1021\/jm900647e","article-title":"'2-{3-[4-(Alkylsulfinyl)phenyl]-1-benzofuran-5-yl}-5-methyl-1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta with good brain permeability'","volume":"52","author":"Saitoh","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2022.108966_bib107","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"'Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease'","volume":"370","author":"Salloway","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2022.108966_bib143","doi-asserted-by":"crossref","DOI":"10.2337\/dc20-0892","article-title":"Metformin use is associated with slowed cognitive decline and reduced incident dementia in older adults with type 2 diabetes: The Sydney memory and ageing study","author":"Samaras","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.neuropharm.2022.108966_bib108","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1172\/JCI90606","article-title":"'Microglia in Alzheimer's disease'","volume":"127","author":"Sarlus","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2022.108966_bib109","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"'Alzheimer's disease'","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2022.108966_bib110","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1046\/j.1471-4159.2002.01243.x","article-title":"'Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia'","volume":"83","author":"Schmid","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.108966_bib111","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/mp.2016.23","article-title":"'Novel osmotin inhibits SREBP2 via the AdipoR1\/AMPK\/SIRT1 pathway to improve Alzheimer's disease neuropathological deficits'","volume":"22","author":"Shah","year":"2017","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.108966_bib112","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1002\/jcb.26036","article-title":"'Molecular interaction of anti-diabetic drugs with acetylcholinesterase and sodium glucose Co-transporter 2'","volume":"118","author":"Shakil","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.neuropharm.2022.108966_bib113","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pneurobio.2018.12.006","article-title":"'Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies'","volume":"174","author":"Sharma","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.108966_bib114","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf6295","article-title":"'Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP\/PS1 mice'","volume":"9","author":"Shi","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuropharm.2022.108966_bib115","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024954","article-title":"'Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus'","volume":"9","author":"Shi","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.neuropharm.2022.108966_bib116","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jalz.2015.06.1893","article-title":"'Phase 3 solanezumab trials: secondary outcomes in mild Alzheimer's disease patients'","volume":"12","author":"Siemers","year":"2016","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuropharm.2022.108966_bib117","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s001250051591","article-title":"'Advanced glycation end-products: a review'","volume":"44","author":"Singh","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.neuropharm.2022.108966_bib118","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz234","article-title":"'Metformin and risk of Alzheimer's disease among community-dwelling people with diabetes: a national case-control study'","volume":"105","author":"Sluggett","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2022.108966_bib119","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3233\/JAD-151200","article-title":"'Metformin facilitates amyloid-beta generation by beta- and gamma-secretases via autophagy activation'","volume":"51","author":"Son","year":"2016","journal-title":"J. Alzheim. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2022.108966_bib120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1471-4159.2011.07515.x","article-title":"'Regulation of beta-site APP-cleaving enzyme 1 gene expression and its role in Alzheimer's disease'","volume":"120","author":"Sun","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.108966_bib121","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3233\/JAD-170585","article-title":"'Mitochondria and mitochondrial cascades in Alzheimer's disease'","volume":"62","author":"Swerdlow","year":"2018","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuropharm.2022.108966_bib122","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.7150\/thno.44962","article-title":"'Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease'","volume":"10","author":"Syal","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.neuropharm.2022.108966_bib123","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jalz.2013.12.007","article-title":"'The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease'","volume":"10","author":"Talbot","year":"2014","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuropharm.2022.108966_bib124","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/2211-5463.12436","article-title":"'Metformin treatment ameliorates diabetes-associated decline in hippocampal neurogenesis and memory via phosphorylation of insulin receptor substrate 1'","volume":"8","author":"Tanokashira","year":"2018","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.neuropharm.2022.108966_bib134","doi-asserted-by":"crossref","DOI":"10.1007\/s11357-020-00169-1","article-title":"Drug synergy as a strategy for compression of morbidity in a Caenorhabditis elegans model of Alzheimer\u2019s disease","author":"Teo","year":"2020","journal-title":"Geroscience"},{"key":"10.1016\/j.neuropharm.2022.108966_bib125","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.bbrc.2020.10.075","article-title":"'Metformin alleviates high glucose-induced ER stress and inflammation by inhibiting the interaction between caveolin1 and AMPKalpha in rat astrocytes'","volume":"534","author":"Wang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2022.108966_bib126","doi-asserted-by":"crossref","first-page":"112874","DOI":"10.1016\/j.ejmech.2020.112874","article-title":"'Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3beta inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents'","volume":"209","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2022.108966_bib127","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fncel.2020.00170","article-title":"'Metformin ameliorates synaptic defects in a mouse model of AD by inhibiting Cdk5 activity'","volume":"14","author":"Wang","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.108966_bib142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212293","article-title":"Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer\u2019s disease: Pooled analysis from 5 cohorts","author":"Weinstein","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2022.108966_bib128","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/alz.12161","article-title":"'Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status'","volume":"16","author":"Wu","year":"2020","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.neuropharm.2022.108966_bib129","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s13238-021-00858-3","article-title":"'Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model'","volume":"12","author":"Xu","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.neuropharm.2022.108966_bib136","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-190123","article-title":"Resveratrol and Metformin Recover Prefrontal Cortex AMPK Activation in Diet-Induced Obese Mice but Reduce BDNF and Synaptophysin Protein Content","author":"Yang","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.neuropharm.2022.108966_bib130","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1039\/C9FO02611H","article-title":"'The effects of caloric restriction and its mimetics in Alzheimer's disease through autophagy pathways'","volume":"11","author":"Yang","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.neuropharm.2022.108966_bib131","doi-asserted-by":"crossref","first-page":"7748","DOI":"10.1096\/fj.201802718R","article-title":"'Metformin treatment improves the spatial memory of aged mice in an APOE genotype-dependent manner'","volume":"33","author":"Zhang","year":"2019","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuropharm.2022.108966_bib132","first-page":"23233","article-title":"'NEAT1 regulates microtubule stabilization via FZD3\/GSK3beta\/P-tau pathway in SH-SY5Y cells and APP\/PS1 mice'","volume":"12","author":"Zhao","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.neuropharm.2022.108966_bib133","first-page":"4847812","article-title":"'Metformin inhibits advanced glycation end products-induced inflammatory response in murine macrophages partly through AMPK activation and RAGE\/NFkappaB pathway suppression'","author":"Zhou","year":"2016","journal-title":"J. Diabetes Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822000259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822000259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:17:40Z","timestamp":1758439060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":141,"alternative-id":["S0028390822000259"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.108966","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the dual character of metformin in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.108966","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108966"}}